Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONTRIBUTED SURPLUS-WARRANT RESERVE (Tables)

v3.22.1
CONTRIBUTED SURPLUS-WARRANT RESERVE (Tables)
12 Months Ended
Dec. 31, 2021
Contributed Surplus [Abstract]  
Summary of Contributed Surplus-Warrant Reserve

As at December 31, 2021, the following equity warrants were outstanding:

Issue Date

Expiry Date

Exercise Price

Currency

Number Issued

Number Outstanding

$

27-Mar-20

27-Mar-25

0.21

USD

154,350

93,100

06-May-20

06-Nov-25

0.45

USD

125,455

73,343

10-Jun-20

10-Jun-24

1.25

USD

1,260,000

643,387

26-Jan-21

26-Jan-23

1.94

USD

518,234

515,834

26-Jan-21

26-Jan-26

2.00

USD

3,709,677

3,123,377

24-Feb-21

24-Feb-23

3.00

USD

4,792,625

4,792,625

24-Feb-21

24-Feb-23

3.00

USD

670,967

670,967

Balance at December 31, 2021

11,231,308

9,912,633

Schedule of Warrants Issued and Outstanding

The Company issued 9,691,503 warrants pursuant to the equity offerings closed in January and February of 2021. Each warrant entitled the holder to purchase one common share at a fixed price, these warrants were classified as equity under IAS 32. These equity warrants expire between January 26, 2023 and November 6, 2025 and are not revalued at each reporting period.

Equity Warrants

Average exercise price

Warrant Reserve

$

$

Balance at January 1, 2020

591,911

3.40

642

Issuance of broker warrants

1,539,805

1.08

1,029

Balance at January 1, 2021

2,131,716

1.72

1,671

January 2021 Equity Offering

3,709,677

2.00

3,164

January 2021 Equity Offering-broker warrants

518,234

1.94

1,384

February 2021 Equity Offering

4,792,625

3.00

5,928

February 2021 Equity Offering-broker warrants

670,967

3.00

1,238

Exercised

(1,318,675

)

1.51

(994

)

Expired

(591,911

)

3.40

(642

)

Balance at December 31, 2021

9,912,633

2.47

11,749